Rheumatoid Arthritis Newswire

Comprehensive Real-Time News Feed for Rheumatoid Arthritis.

Results 1 - 20 of 2,150 in Rheumatoid Arthritis

  1. Patent Issued for Method of Treating a Patient Having an Autoimmune...Read the original story

    2 hrs ago | Hispanic Business

    ... contribute to the pathogenesis of autoimmune diseases, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis. For a review, see, e.g., Mackay et al. (2002) Nature Reviews: Immunology, 2:465-475; Kalled et al. (2003) Expert Opin. Ther. ...

    Comment?

  2. Findings from Stanford University Update Understanding of Rheumatoid...Read the original story

    2 hrs ago | Hispanic Business

    Editor at Biotech Week -- New research on Autoimmune Diseases is the subject of a report. According to news originating from , by NewsRx correspondents, research stated, "To evaluate safety and efficacy of weekly and every other week dosing of sarilumab, a fully human anti-interleukin 6 receptor a monoclonal antibody, for moderate-to-severe rheumatoid arthritis .

    Comment?

  3. Survey: RA Drug Market Driven by Uptake of Oral Jak Inhibitors and Non - "TNF-Alpha BiologicsRead the original story

    4 hrs ago | P&T Community

    Decision Resources Group, a health care research firm located in Burlington, Mass., finds that the rheumatoid arthritis disease-modifying antirheumatic drug market will increase from $14 billion in 2013 to more than $18.2 billion in 2023 in the U.S., Europe, and Japan. According to the report, tumor necrosis factor -alpha inhibitors will remain the leading drug class in both sales and patient shares in the RA market, but growth will be constrained and patient shares will decline because of the uptake of oral Janus kinase inhibitors and the entry of alternative biologic agents.

    Comment?

  4. Can-Fite Files June 30, 2014 Interim Financial StatementsRead the original story

    5 hrs ago | Sys-Con Media

    ... trials for the treatment of psoriasis and the Company is preparing for a Phase III CF101 trial for rheumatoid arthritis. Can-Fite's liver cancer drug CF102 is commencing Phase II trials and has been granted Orphan Drug Designation by the U.S. Food ...

    Comment?

  5. Salt and smoking may interact to raise rheumatoid arthritis riskRead the original story

    6 hrs ago | Reuters

    Eating a diet high in salt may increase the risk of rheumatoid arthritis among smokers, according to a large study from Sweden. Researchers set out to see if a salty diet might be linked to the onset of RA, but found a connection only among smokers - who were more than twice as likely as anyone with a low-salt diet to develop the condition.

    Comment?

  6. Clever tool tips for arthritic gardenersRead the original story w/Photo

    6 hrs ago | Examiner.com

    ... quits. Be careful out there. Enjoy yourself in the garden. Don't let it cripple you for life. I've had rheumatoid arthritis since I was young. So far, I'm controlling it by using common sense and natural healing. Part of that common sense is using ...

    Comment?

  7. ImaginAb Expands ImmunoPET Pipeline to Include CD4+ T-Cell ImagingRead the original story

    10 hrs ago | Freshnews

    ... selection and therapeutic response assessment in a variety of clinically important diseases including rheumatoid arthritis and Crohn's disease. "We believe that CD4 imaging has broad applicability to further understand how to treat diseases that ...

    Comment?

  8. RXi Pharmaceuticals Strengthens Intellectual Property PortfolioRead the original story

    13 hrs ago | BioSpace

    Potential diseases include, but are not limited to, macular degeneration, rheumatoid arthritis and Crohn's disease. The patent covers the use of rxRNAori in a complex containing a phagocytic cell-targeting moiety.

    Comment?

  9. Can-Fite BioPharma's Drug CF101 Is Presented In Scientific Journal...Read the original story

    13 hrs ago | BioSpace

    ... trials for the treatment of psoriasis and the Company is preparing for a Phase III CF101 trial for rheumatoid arthritis. Can-Fite's liver cancer drug CF102 is commencing Phase II trials and has been granted Orphan Drug Designation by the U.S. Food ...

    Comment?

  10. Research and Markets: Global Biomaterials Market for Implantable...Read the original story

    11 hrs ago | Business Wire

    ... demand of biomaterials for manufacturing high quality devices. Rising prevalence of osteoarthritis, rheumatoid arthritis and sports injuries are driving the demand for orthopedic implants which in turn increases the demand for biomaterials. In ...

    Comment?

  11. Kinase in Motion: Insights into the Dynamic Nature of p38I by...Read the original story

    12 hrs ago | CiteULike

    ... mitogen-activated protein kinase (MAPK). p38I plays a central role in inflammatory diseases such as rheumatoid arthritis and is therefore a highly attractive pharmaceutical target. The combination of high pressure and NMR spectroscopy allowed for a ...

    Comment?

  12. Recognizing the telltale signs of osteoporosisRead the original story w/Photo

    15 hrs ago | Los Altos Town Crier

    ... It can also occur in anyone with a disorder that affects bone development, such as celiac disease, rheumatoid arthritis, inflammatory bowel disease or kidney dysfunction. Prolonged use of steroids or blood thinners may increase your risk for ...

    Comment?

  13. Rollins named Phillies' nominee for Clemente AwardRead the original story w/Photo

    21 hrs ago | Philadelphia Phillies

    ... hosted major fundraisers to contribute to The Juvenile Diabetes Research Foundation (JDRF); Juvenile Rheumatoid Arthritis Foundation (JRA); Prevent Child Abuse, Pennsylvania; The Food Trust; SHARE Food Program and St. Christopher's Foundation for ...

    Comment?

  14. Criterion validation of two submaximal aerobic fitness tests, the...Read the original story

    23 hrs ago | BioMed Central

    ... Fox-walk test and the submaximal Astrand cycle test against a maximal cycle test in people with rheumatoid arthritis (RA). A secondary aim was to study the influence of different formulas for age predicted maximal heart rate when estimating VO2max ...

    Comment?

  15. Mechanistic Insights Into the Link Between Inflammation and...Read the original story

    Jul 15, 2014 | Circulation

    Correspondence to Katherine P. Liao, MD, MPH, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, 75 Francis St, PBB-B3, Boston, MA 02115. E-mail Thirty years ago, a diagnosis of rheumatoid arthritis resigned the majority of patients to a lifetime of chronic inflammation and progressive joint destruction.

    Comment?

  16. Stopping schizophrenia before birthRead the original story w/Photo

    Tuesday | KLAS-TV Las Vegas

    ... to the brain. new study may help scientists unlock a medical mystery. Researchers have found that rheumatoid arthritis patients seem to have protection from developing Alzheimer's disease. The scientific link between the two may help researchers ...

    Comment?

  17. Phillies: Jimmy Rollins nominated for Roberto Clemente AwardRead the original story w/Photo

    Tuesday | NJ.com

    ... hosted major fundraisers to contribute to The Juvenile Diabetes Research Foundation (JDRF), Juvenile Rheumatoid Arthritis Foundation (JRA), Prevent Child Abuse, Pennsylvania, The Food Trust, SHARE Food Program and St. Christopher's Foundation for ...

    Comment?

  18. The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in...Read the original story

    Tuesday | Freshnews

    Decision Resources Group finds that the rheumatoid arthritis disease-modifying antirheumatic drug market will increase from $14 billion in 2013 to over $18.2 billion in 2023 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. TNF-alpha inhibitors will remain the leading drug class in both sales and patient shares in the RA market, but growth will be constrained and patient shares will decline due to the uptake of oral Janus kinase inhibitors and the entry of alternative biological agents.

    Comment?

  19. Acquisition Of Navarro To Expand CVS' Hispanic Customer Base & Specialty Drugs ShareRead the original story w/Photo

    Tuesday | Forbes.com

    ... focus on developing this business. Specialty drugs treat complex diseases such as multiple sclerosis, rheumatoid arthritis, hepatitis C and cancer, among others. CVS operates approximately 30 retail specialty pharmacy stores (under the ...

    Comment?

  20. Patients with particular genetic variation more prone to drug-induced pancreatitisRead the original story w/Photo

    Tuesday | Medical News

    ... commonly used drugs to suppress the immune system in the treatment of Inflammatory Bowel Disease (IBD), rheumatoid arthritis and after some organ transplants. It has long been recognised that about four per cent of patients who are prescribed these ...

    Comment?